Millipore Sigma Vibrant Logo
Attention: We have moved. EMD Millipore products are no longer available for purchase on emdmillipore.com.Learn More

481920 NAAG - CAS 3106-85-2 - Calbiochem

Overview

Replacement Information

Key Specifications Table

CAS #Empirical Formula
3106-85-2C₁₁H₁₆N₂O₈

Products

Catalog NumberPackaging Qty/Pack
481920-50MG Glass bottle 50 mg
Description
OverviewNAAG is a neuropeptide and a neurotransmitter that is abundant in the mammalian nervous system. It remains uncertain whether this compound activates NMDA receptors; however, it is clearly demonstrated to act as a selective agonist of mGluR3, both in vitro and in vivo.
Catalogue Number481920
Brand Family Calbiochem®
SynonymsN-Acetyl-Asp-Glu, N-acetylaspartylglutamate; Spaglumic acid
References
ReferencesNeale, J., et al. 2011. J. Neurochem. 12, in press; Neal, J., et al. 2011. J. Neurochem. 118, 490; Adedoyin, M., et al. 2010. Mol. Pain 6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther. 330, 212; Fricker, A., et al. 2009. Neuropharmacology 56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci. 29, 477; Westbrook, G., et al. 1986. J. Neurosci. 11, 3385; Koller, K., et al. 1984. J. Neurochem. 43, 1136; Curatolo, A., et al. 1965, J. Neurochem. 12, 339.
Product Information
CAS number3106-85-2
FormWhite powder
Hill FormulaC₁₁H₁₆N₂O₈
Chemical formulaC₁₁H₁₆N₂O₈
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Purity≥98% by TLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Regulatory Review
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalog Number GTIN
481920-50MG 04055977225686

Documentation

NAAG - CAS 3106-85-2 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

NAAG - CAS 3106-85-2 - Calbiochem Certificates of Analysis

TitleLot Number
481920

References

Reference overview
Neale, J., et al. 2011. J. Neurochem. 12, in press; Neal, J., et al. 2011. J. Neurochem. 118, 490; Adedoyin, M., et al. 2010. Mol. Pain 6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther. 330, 212; Fricker, A., et al. 2009. Neuropharmacology 56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci. 29, 477; Westbrook, G., et al. 1986. J. Neurosci. 11, 3385; Koller, K., et al. 1984. J. Neurochem. 43, 1136; Curatolo, A., et al. 1965, J. Neurochem. 12, 339.

Brochure

Title
Pathways and Biomarkers of Glutamatergic Synapse Flyer
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision03-April-2012 JSW
SynonymsN-Acetyl-Asp-Glu, N-acetylaspartylglutamate; Spaglumic acid
DescriptionNAAG is a neuropeptide and a neurotransmitter that is abundant in the mammalian nervous system. It remains uncertain whether this compound activates NMDA receptors; however, it is clearly demonstrated to act as a selective agonist of mGluR3, both in vitro and in vivo.
FormWhite powder
Intert gas (Yes/No) Packaged under inert gas
CAS number3106-85-2
Chemical formulaC₁₁H₁₆N₂O₈
Structure formulaStructure formula
Purity≥98% by TLC
SolubilityDMSO (50 mg/ml) or Methanol (50 mg/ml)
Storage Protect from light
+2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Regulatory Review
ReferencesNeale, J., et al. 2011. J. Neurochem. 12, in press; Neal, J., et al. 2011. J. Neurochem. 118, 490; Adedoyin, M., et al. 2010. Mol. Pain 6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther. 330, 212; Fricker, A., et al. 2009. Neuropharmacology 56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci. 29, 477; Westbrook, G., et al. 1986. J. Neurosci. 11, 3385; Koller, K., et al. 1984. J. Neurochem. 43, 1136; Curatolo, A., et al. 1965, J. Neurochem. 12, 339.